Stock VIAP VIA PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases VIA Pharmaceuticals, Inc.

Equities

VIAP

US92554T1034

Market Closed - OTC Markets
Other stock markets
 10:20:07 2024-03-07 EST 		5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for VIA Pharmaceuticals, Inc. -.--% -99.00%

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
VIA PHARM : VIA Pharmaceuticals Receives Delisting Notification From NASDAQ
PR
VIA PHARM : VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291
PR
VIA PHARM : VIA Pharmaceuticals Featured at Cambridge Healthtech Institute Discovery on Target 2009 Conference
PR
VIA PHARM : VIA Pharmaceuticals Receives Favorable Hearing Decision From NASDAQ
PR
VIA PHARM : VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ
PR
VIA PHARM : VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ
PR
VIA PHARM : VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
PR
VIA PHARMACEUTICAL COM STK USD0.001 : VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals Receives Anticipated Notice From NASDAQ
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals Complies With NASDAQ Rules
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals Secures Financing Up to $10.0 Million
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals Licenses Drug Candidates from Roche to Expand Cardiovascular Pipeline to Include Metabolic Disease
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals Announces Upcoming Investor Conference Presentations
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals to Host Investor Science Briefing on the Role of Inflammation in Cardiovascular Disease on Tuesday, September 16
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals to Present at Merriman Curhan Ford's Investor Summit 2008
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery & Development of Innovative Therapeutics World Congress
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals Set to Join Russell Microcap Index
PR
VIA PHARMACEUTICAL : VIA Pharmaceuticals to Present at Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VIAP Stock
  4. News VIA Pharmaceuticals, Inc.
  5. Press Releases